Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 15 hours agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
SARS-CoV-2 vaccine does not increase new-onset seizure risk
Medical Xpress· 4 days agoThere is no risk for new-onset seizure incidence for individuals receiving a severe acute...
Common diabetes drug lowers SARS-CoV-2 levels, clinical trial finds
Center for Infectious Disease Research and Policy· 18 hours agoToday, researchers from the University of Minnesota published evidence that the common diabetes drug...
...WHO) Statement on the Antigen Composition of COVID-19 Vaccines - SARS-CoV-2 Continues to...
Sierra Sun Times· 6 days agoSARS-CoV-2 continues to circulate and evolve with important genetic and antigenic evolution of the spike protein. The objective of an ...
ESCMID Presenters Make Case for Saliva Samples in Molecular Infectious Disease Testing
GenomeWeb News· 4 days agoSaliva is a promising sample type for molecular diagnostic testing in infectious diseases beyond ...
A Man Had Covid For 613 Straight Days—and Created a Whole New Mutation
Prevention via Yahoo News· 3 days agoWhen the world first woke up to the seriousness of the COVID-19 pandemic, the SARS-CoV-2 coronavirus...
What to Know About the 'FLiRT' Variants of COVID-19
Time Magazine· 5 days agoThe COVID-19 lull in the U.S. may soon come to an end, as a new family of SARS-CoV-2 variants—nicknamed “FLiRT” variants—begins to spread ...
COVID-19 Proteins Can Hang Around In The Blood For Up To 14 Months After Infection
IFLScience· 5 days agoThe idea that SARS-CoV-2, the virus behind COVID-19, may be able to persist in the body long after...
Quiz: Can you pass our 9 question test on the latest theories of COVID-19 transmission
WLRN Miami· 5 days agoThe arrival of SARS-CoV-2, the virus responsible for COVID-19, brought a batch of vocabulary into...
Scientists tried to give people COVID — and failed
Nature· 4 days agoResearchers deliberately infect participants with SARS-CoV-2 in ‘challenge’ trials — but high levels of immunity complicate efforts to test vaccines and...